Angioødem - udredning og behandling

Tidsskrift for den Norske Laegeforening

Volumn 132, Issue 21, 2012, Pages 2391-2395

  Rye Rasmussen, Eva H ^a   Bindslev Jensen, Carsten ^a,b   Bygum, Anette ^a,b  

^a Køge øre næse hals afdeling ^*  (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANGIONEUROTIC EDEMA; CLASSIFICATION; CLINICAL PATHWAY; DIFFERENTIAL DIAGNOSIS; HUMAN; REVIEW; URTICARIA;

ALGORITHMS; ANGIOEDEMA; CRITICAL PATHWAYS; DIAGNOSIS, DIFFERENTIAL; HUMANS; URTICARIA;

EID: 84871984940     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.12.0470     Document Type: Article

References (46)

1. Champion RH, Roberts SOB, Carpenter RG et al. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969; 81: 588-97.
2. Frigas E, Nzeako UC. Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 2002; 23: 217-31.
3. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005; 53: 373-88, quiz 389-92.
4. Frigas E, Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 2006; 26: 739-51.
5. Zingale LC, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006; 175: 1065-70.
6. Tai S, Mascaro M, Goldstein NA. Angioedema: a review of 367 episodes presenting to three tertiary care hospitals. Ann Otol Rhinol Laryngol 2010; 119: 836-41.
7. Lerch M. Drug-induced angioedema. Chem Immunol Allergy 2012; 97: 98-105.
8. Agostoni A, Aygören-Pürsün E, Binkley KE et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114 (suppl): S51-131.
9. Bowen T, Cicardi M, Farkas H et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6: 24.
10. Åbom A, Palarasah Y, Bygum A. Flere nye behandlingsmuligheder til hereditært angioødem. Ugeskr Læger 2012; 174: 1894-8.
11. Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol 2011; 7 (suppl 1): S9.
12. Madsen F, Attermann J, Linneberg A. Epidemiology of non-hereditary angioedema. Acta Derm Venereol 2012. E-publisert 9.7. doi: 10.2340/00015555-1389.
13. Sánchez-Borges M, González-Aveledo LA. Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2010; 2: 195-8.
14. Vleeming W, van Amsterdam JG, Stricker BH et al. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998; 18: 171-88.
15. Miller DR, Oliveria SA, Berlowitz DR et al. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 2008; 51: 1624-30.
16. Mahoney EJ, Devaiah AK. Angioedema and angiotensin-converting enzyme inhibitors: are demographics a risk? Otolaryngol Head Neck Surg 2008; 139: 105-8.
17. Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005; 165: 1637-42.
18. Holm JP, Ovesen T. Increasing rate of angiotensinconverting enzyme inhibitor-related upper airway angio-oedema. Dan Med J 2012; 59: A4449.
19. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004; 164: 317-9.
20. Casale TB, Sampson HA, Hanifin J et al. Guide to physical urticarias. J Allergy Clin Immunol 1988; 82: 758-63.
21. Wedi B, Raap U, Wieczorek D et al. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5: 10.
22. Fitzharris P, Jordan A. Investigating recurrent angio-oedema. BMJ 2011; 343: d6607.
23. Caballero T, Baeza ML, Cabañas R et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 2011; 21: 333-47, quiz 347.
24. Suhrs HE, Ibsen H. Forekomst af angioødem ved blokering af renin-angiotensin-aldosteron-systemet. Ugeskr Læger 2012; 174: 724-9.
25. Adam A, Cugno M, Molinaro G et al. Aminopeptidase P in individuals with a history of angiooedema on ACE inhibitors. Lancet 2002; 359: 2088-9.
26. Byrd JB, Shreevatsa A, Putlur P et al. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. J Allergy Clin Immunol 2007; 120: 403-8.
27. Brown NJ, Byiers S, Carr D et al. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 2009; 54: 516-23.
28. Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol Allergy Clin North Am 2006; 26: 709-24.
29. Skogøy K, Nielsen EW. En 24 år gammel kvinne med utslett og hevelser under p-pillebruk og graviditet. Tidsskr Nor Lægeforen 2006; 126: 2806-7.
30. Bouillet L, Ponard D, Drouet C et al. Angioedema and oral contraception. Dermatology 2003; 206: 106-9.
31. Gordon EM, Ratnoff OD, Saito H et al. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762-9.
32. Zingale LC, Castelli R, Zanichelli A et al. Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am 2006; 26: 669-90.
33. Gleich GJ, Schroeter AL, Marcoux JP et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984; 310: 1621-6.
34. Banerji A, Weller PF, Sheikh J. Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's Syndrome). Immunol Allergy Clin North Am 2006; 26: 769-81.
35. Shadick NA, Liang MH, Partridge AJ et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol 1999; 104: 123-7.
36. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 1999; 130: 905-9.
37. Kozel MM, Mekkes JR, Bossuyt PM et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998; 134: 1575-80.
38. http://www.drugeruptiondata.com
39. Malling HJ, Hansen KS. Anafylaksi. Ugeskr Læger 2005; 167: 664-6.
40. Fast S, Henningsen E, Bygum A. Icatibant er en ny behandlingsmulighed ved livstruende angiotensinkonverterende enzym-inhibitor-udløst angioødem. Ugeskr Læger 2011; 173: 2574-5.
41. Bas M, Greve J, Stelter K et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 2010; 56: 278-82.
42. Büyüköztürk S, Gelincik A, Demirtürk M et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol 2012; 39: 439-42.
43. Du-Thanh A, Raison-Peyron N, Drouet C et al. Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy 2010; 65: 793-5.
44. Munch EP, Weeke B. Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later. Allergy 1985; 40: 92-7.
45. Zuberbier T, Balke M, Worm M et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35: 869-73.
46. Bygum A. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol 2009; 161: 1153-8.